- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1432-1238
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Anmerkungen
-
online resource.
- Erschienen in
-
Ten things the hematologist wants you to know about CAR-T cells ; volume:46 ; number:6 ; day:30 ; month:3 ; year:2020 ; pages:1243-1245 ; date:6.2020
Intensive care medicine ; 46, Heft 6 (30.3.2020), 1243-1245, 6.2020
- Urheber
- Beteiligte Personen und Organisationen
-
SpringerLink (Online service)
- DOI
-
10.1007/s00134-020-06002-9
- URN
-
urn:nbn:de:101:1-2020081020084839774035
- Rechteinformation
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
14.08.2025, 10:55 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Böll, Boris
- Subklewe, Marion
- Bergwelt-Baildon, Michael von
- SpringerLink (Online service)
Ähnliche Objekte (12)
Engineering CAR-T cells
Mr. Bull wants to know "the reason why"
Femoroacetabular Impingement: What the Surgeon Wants to Know
Cost of implementing CAR-T activity and managing CAR-T patients: an exploratory study
Pancreatic Cancer Imaging: What the Surgeon Wants to Know?
Gut microbiome and CAR-T therapy
Strategies to enhance CAR-T persistence
Target selection for CAR-T therapy
Interleukin-7 expression by CAR-T cells improves CAR-T cell survival and efficacy in chordoma
New development in CAR-T cell therapy
Recent advances in CAR-T cell engineering
CAR-T Cell Therapy for Solid Tumors
Engineering CAR-T cells
Mr. Bull wants to know "the reason why"
Femoroacetabular Impingement: What the Surgeon Wants to Know
Cost of implementing CAR-T activity and managing CAR-T patients: an exploratory study
Pancreatic Cancer Imaging: What the Surgeon Wants to Know?
Gut microbiome and CAR-T therapy
Strategies to enhance CAR-T persistence
Target selection for CAR-T therapy
Interleukin-7 expression by CAR-T cells improves CAR-T cell survival and efficacy in chordoma
New development in CAR-T cell therapy
Recent advances in CAR-T cell engineering
CAR-T Cell Therapy for Solid Tumors
Engineering CAR-T cells
Mr. Bull wants to know "the reason why"
Femoroacetabular Impingement: What the Surgeon Wants to Know
Cost of implementing CAR-T activity and managing CAR-T patients: an exploratory study
Pancreatic Cancer Imaging: What the Surgeon Wants to Know?
Gut microbiome and CAR-T therapy
Strategies to enhance CAR-T persistence
Target selection for CAR-T therapy
Interleukin-7 expression by CAR-T cells improves CAR-T cell survival and efficacy in chordoma
New development in CAR-T cell therapy
Recent advances in CAR-T cell engineering